Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP-Reference-Cited by-同舟云学术

Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP

Published:2021-07 Issue:5 Volume:11 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical and Translational Allergy

Author:

Mümmler Carlo¹²,Dünzelmann Kristin¹²,Kneidinger Nikolaus¹²,Barnikel Michaela¹²,Munker Dieter¹²,Gröger Moritz³,Canis Martin³,Behr Jürgen¹²,Koch Andrea⁴,Haubner Frank³,Milger Katrin¹^ORCID

Affiliation:

1. Department of Medicine V University Hospital LMU Munich Munich Germany

2. Comprehensive Pneumology Center (CPC‐M) LMU and Helmholtz Center Munich Munich Germany

3. Department of Otorhinolaryngology University Hospital LMU Munich Munich Germany

4. Abteilung für Lungenheilkunde Pyhrn‐Eisenwurzen Klinikum Steyr Munich Austria

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clt2.12049

Reference7 articles.

1. Asthma-related comorbidities

2. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

3. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

4. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

5. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis;Journal of Asthma and Allergy;2024-06

2. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye;Medicina;2024-03-08

3. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence;Expert Opinion on Biological Therapy;2024-01-30

4. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists;World Allergy Organization Journal;2023-12

5. Direct comparative study of the effectiveness of mepolizumab and dupilumab in patients with severe non-allergic eosinophilic asthma;Meditsinskiy sovet = Medical Council;2023-11-07